Chitchamai Ovatlarnporn | Drug development | Best Researcher Award

Assist Prof Dr. Chitchamai Ovatlarnporn | Drug development | Best Researcher Award

Assist Prof Dr. Chitchamai Ovatlarnporn at Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hatyai, Songkhla, Thailand

👨‍🎓Professional Profiles

🧑‍🏫 Early Academic Pursuits

Dr. Chitchamai Ovatlarnporn’s academic journey began with a solid foundation in pharmacy. She earned her Bachelor of Pharmacy (Second Honours) from Songkhla University in 1990. Building on this, she went on to pursue higher education internationally, receiving a Master’s Degree in Biotechnology from the University of Kent at Canterbury in 1993, and later obtaining a Ph.D. in Chemistry from the University of Ottawa in 2000. This educational progression laid the groundwork for her distinguished career in pharmaceutical sciences, particularly in the areas of drug delivery systems, medicinal chemistry, and biotechnology.

💼 Professional Endeavors

Dr. Ovatlarnporn’s professional career has been deeply intertwined with both academic and research excellence. She holds a prominent position as an Associate Professor at the Faculty of Pharmaceutical Sciences, Prince of Songkla University (PSU), Thailand. In addition to her teaching responsibilities, she is a pivotal figure in the Department of Pharmaceutical Chemistry at PSU, where she focuses on cutting-edge pharmaceutical research, particularly related to drug development and delivery systems. Over the years, she has successfully combined her roles as an educator, researcher, and consultant in various national and international research projects.

Her expertise extends to consulting for product development and research with projects like Move World Together and Tech2BiZ, reflecting her dynamic role in fostering innovation within the pharmaceutical and biotechnology industries.

🔬 Contributions and Research Focus

Dr. Ovatlarnporn’s research is diverse and far-reaching, focusing primarily on drug delivery systems, pharmaceutical chemistry, and biotechnology. One of her major research interests lies in the development of nanotechnology-based drug delivery systems, such as the preparation and evaluation of nanomicelles for enhanced solubility and bioavailability of poorly water-soluble drugs like curcumin and resveratrol.

She has also made significant contributions to pharmacological research, investigating the antioxidant, anti-inflammatory, and anticancer properties of various medicinal plants and their bioactive compounds. Her work also includes genetic engineering, the synthesis of novel compounds, and the utilization of biopolymers for targeted drug delivery systems, particularly in colon-specific drug delivery.

🌍 Impact and Influence

Dr. Ovatlarnporn’s work has had a significant impact on both the academic and pharmaceutical industries. Her research on tetrhydrocurcumins, curcumin derivatives, and chitosan-based drug delivery systems has opened new avenues for cancer therapy, chronic disease management, and sustainable biopharmaceutical innovations.

Her published works are frequently cited in high-impact journals such as Food Bioscience, Journal of Drug Delivery Science and Technology, and Molecules, making her an influential researcher in her field. Her studies on natural compounds such as Viola stocksii and Tiliacora triandra have advanced the scientific understanding of their pharmacological potentials, contributing to the growing body of knowledge in natural product-based drug development.

📚 Academic Cites & Recognition

Dr. Ovatlarnporn has authored and co-authored numerous peer-reviewed papers, making significant contributions to the fields of medicinal chemistry, pharmaceutical biotechnology, and drug delivery systems. Notable publications include:

  • “Evaluation of the Anti-Inflammatory, Antioxidant, and Cytotoxic Potential of Cardamine Amara L.” published in Frontiers in Chemistry (Impact Factor: 5.5).
  • “Insights into the remarkable attenuation of hen egg white lysozyme amyloid fibril formation mediated by biogenic gold nanoparticles” in the International Journal of Biological Macromolecules (Impact Factor: 8.2).
  • Research on Acanthus ebracteatus and its bioactive properties, published in Molecules.

Her work is widely recognized, with her publications frequently cited by fellow researchers and practitioners in the pharmaceutical sciences, demonstrating her high standing in the global research community.

🛠 Technical Skills

Dr. Ovatlarnporn is proficient in a wide range of technical skills essential to her research work. These include:

  • Nanotechnology and Drug Delivery Systems: Expertise in the preparation and evaluation of drug formulations, particularly nanomicelles and nanoemulsions.
  • Medicinal Chemistry: Deep knowledge of bioactive natural products, their chemical properties, and potential therapeutic applications.
  • Pharmacological Research: Extensive experience in designing and conducting in vitro and in vivo studies to assess the biological activity of plant-based compounds.
  • Analytical Techniques: Skilled in HPLC, GC-MS, NMR, and spectroscopic methods for the identification and quantification of bioactive compounds.
  • Molecular Docking & Computational Studies: Proficient in using in silico models for studying molecular interactions and optimizing drug efficacy.

👨‍🏫 Teaching Experience

As an academic leader at Prince of Songkla University, Dr. Ovatlarnporn has had a profound influence on shaping the next generation of pharmaceutical scientists. Her teaching areas cover various aspects of medicinal chemistry, drug delivery systems, biotechnology, and pharmaceutical technology. She is known for integrating cutting-edge research findings into her curriculum, ensuring that students are exposed to the latest advancements in the field. Her mentoring has inspired numerous graduate students, many of whom have gone on to achieve their own academic and professional successes.

🌱 Legacy and Future Contributions

Looking forward, Dr. Ovatlarnporn is committed to advancing research on nanotechnology and its applications in targeted drug delivery systems. She aims to further her work on sustainable biopharmaceutical innovations and natural product-based therapies, especially in cancer treatment and chronic disease management. Her research in collaboration with industry partners promises to continue to bridge the gap between academic research and commercial product development, ensuring that her contributions have lasting real-world impact.

In the future, Dr. Ovatlarnporn plans to focus on enhancing the bioavailability of natural bioactive compounds, developing more efficient drug delivery platforms, and promoting interdisciplinary collaborations within the fields of pharmacy, biotechnology, and medicine. Her continued dedication to research excellence and academic mentorship ensures her legacy will live on in both the scientific community and the generations of students she has mentored.

Marilena Vlachou | Physical Pharmacy | Most Cited Paper Award

Assoc Prof Dr. Marilena Vlachou | Physical Pharmacy | Most Cited Paper Award

Assoc Prof Dr. Marilena Vlachou at National And Kapodistrian University Of Athens, Greece

👨‍🎓 Profile

📚 Academic Background

Marilena Vlachou pursued her academic studies at the National and Kapodistrian University of Athens (NKUoA), where she completed both her Pharmacy degree and her PhD in Pharmaceutical Technology. Her scholarly journey included a pivotal period as a Visiting Research Scientist at the University of Rhode Island, where she conducted advanced research in Pharmaceutical Technology techniques, enriching her expertise and contributing to her academic and professional development.

🎓Education

Marilena Vlachou completed her Pharmacy degree and PhD in Pharmaceutical Technology at the National and Kapodistrian University of Athens (NKUoA). Her academic journey in the field was further enriched by a stint as a Visiting Research Scientist at the University of Rhode Island, where she engaged in cutting-edge research in Pharmaceutical Technology techniques just before obtaining her PhD.

🏛️ Professional Experience

Before completing her PhD, Marilena Vlachou conducted advanced research as a Visiting Research Scientist at the University of Rhode Island. At NKUoA, she teaches courses in Pharmaceutical Technology, Physical Pharmacy, and Nanotechnology at both undergraduate and postgraduate levels.

🔬 Research Interests

Her research interests lie in Pharmaceutical Technology, Physical Pharmacy, and Nanotechnology. She has published over fifty articles in peer-reviewed journals and co-authored the textbook “Pharmaceutical Technology I: Principles of Physical Pharmacy and Nanotechnology.” She has also presented her work at more than sixty international and domestic scientific conferences.

🌐 Affiliations

Marilena Vlachou is a member of the Greek Pharmaceutical Society, the Greek Society of Pharmaceutical Technology, and the Greek Section of the Society of Controlled Release of Drugs.

📖  Top Noted Publications
Sustained release of 3D printed bupropion hydrochloride tablets bearing Braille imprints for the visually impaired
    • Authors: Protopapa, C., Siamidi, A., Junqueira, L.A., Douroumis, D., Vlachou, M.
    • Journal: International Journal of Pharmaceutics
    • Year: 2024
3D-Printed Melatonin Tablets with Braille Motifs for the Visually Impaired
    • Authors: Protopapa, C., Siamidi, A., Sakellaropoulou, A., Douroumis, D., Vlachou, M.
    • Journal: Pharmaceuticals
    • Year: 2024
In Vitro Profile of Hydrocortisone Release from Three-Dimensionally Printed Paediatric Mini-Tablets
    • Authors: Protopapa, C., Siamidi, A., Kolipaka, S.S., Douroumis, D., Vlachou, M.
    • Journal: Pharmaceutics
    • Year: 2024
In vitro Modified Release Studies on Melatoninergic Fluorinated Phenylalkylamides: Circumventing their Lipophilicity for Oral Administration
    • Authors: Vlachou, M., Siamidi, A., Protopapa, C., Dreliozi, C.-C., Papanastasiou, I.P.
    • Journal: Current Pharmaceutical Design
    • Year: 2024
A Thermal-Analysis-Technique-Based Mechanistic Approach toward the Release of Omeprazole from Solid Dosage Forms
    • Authors: Agapakis, G., Siamidi, A., Kikionis, S., Vlachou, M., Pippa, N.
    • Journal: Scientia Pharmaceutica
    • Year: 2024
Modified Release of Acetaminophen from Matrix Tablet Formulations: Influence of Tablet Geometry
    • Authors: Siamidi, A., Konstantinou, A., Pavlou, P., Siamidis, I., Vlachou, M.
    • Journal: Letters in Drug Design and Discovery
    • Year: 2024

Abrar Mohammad Sayaf | Drugs designing | Best Researcher Award

Mr. Abrar Mohammad Sayaf | Drugs designing | Best Researcher Award

Mr. Abrar Mohammad Sayaf at Universiti Sains Malaysia, Malaysia

Author Profile

Scopus Profile
Biography of Mr. Abrar Mohammad Sayaf: A Distinguished Chemist and Researcher in Drug Design and Natural Product Synthesis 🔬🌍

Mr. Abrar Mohammad Sayaf is a highly accomplished chemist and researcher currently affiliated with the Department of Chemistry at the University of Oxford. His diverse academic and professional background spans several prestigious institutions, reflecting his profound expertise in both theoretical and applied chemistry.

Academic Background 📚

  • Ph.D. in Progress: School of Chemical Sciences, Universiti Sains Malaysia (2022-Present)
  • M.Ed. (1st Division): Alama Iqbal Open University, Islamabad, Pakistan (2016-2019)
  • B.Ed. (1st Division): Alama Iqbal Open University, Islamabad, Pakistan (2012-2014)
  • M.Sc. in Chemistry (University Distinction): University of Swat, Pakistan (2011-2013)
  • B.Sc. (1st Division): University of Malakand, Pakistan (2009-2011)

Professional Experience 🏢

  • Research Fellow: Department of Chemistry, University of Oxford (January 2024-Present)
  • Lecturer in Chemistry: University of Swat, Pakistan (2014-2020)
  • Product Development Analyst: Shaheen Pharmaceuticals, Mingora, Swat (2020-2022)
  • Director and Lecturer in Chemistry: Quantum Academia, Mingora, Swat (2012-2020)

Research Interests and Projects 🔍

  • Current Research: Prolyl Hydroxylase Domain 2 (PHD2) Inhibitors at the University of Oxford, funded by the Fundamental Research Grant Scheme (FRGS)
  • Previous Projects: Biological synthesis of Pd nanoparticles, catalysis in Suzuki cross-coupling reactions, and isolation of natural products from Delphinium roylei and Debregeasia salicifolia

Skills and Expertise 🧪

  • Computational Chemistry: Molecular docking, molecular dynamics simulation, network pharmacology, protein-protein docking, computational vaccine designing, and drug pharmacokinetics/ADMET analysis
  • Organic Synthesis: Amide synthesis, Schiff bases, carbon-carbon coupling
  • Natural Product Chemistry: Isolation and characterization
  • Analytical Techniques: Chromatography, NMR spectroscopy, IR spectroscopy, mass spectrometry, protein crystallization, and alpha screening (IC50 calculation)

Research Collaborations 🤝

  • Schofield Group, University of Oxford, England: Prolyl hydroxylase domains (PHDs) inhibition
  • Qatar University, Doha, Qatar: In silico drug discovery for infectious diseases
  • Shanghai Jiao Tong University, China: In silico drug discovery for viral diseases
  • Hunan University of Science and Technology, China: In silico drug discovery for viral diseases
  • Agri Ibrahim Cecen University, Turkey: Inhibition of carbonic anhydrases
  • University of Swat, Pakistan: In silico drug discovery for cancer treatment

Achievements and Honors 🏆

  • Research Assistance: School of Chemical Sciences, USM, Malaysia (2022-Present)
  • International Summer School Scholarship: University of A Coruña, Spain (2020)
  • University Position Holder: M.Sc. Chemistry at University of Swat (2013)
  • Various Academic Awards: Including speech competitions, talent certificates, and scholarships

📖 Publication Top Noted

Article: Molecular screening of phytocompounds targeting the interface between influenza A NS1 and TRIM25 to enhance host immune responses
  • Authors: Suleman, M., Sayaf, A.M., Khan, A., Yassine, H.M., Crovella, S.
    Journal: Journal of Infection and Public Health
    Volume: 17
    Issue: 7
    Pages: 102448
    Year: 2024
Article: Pharmacotherapeutic Potential of Natural Products to Target the SARS-CoV-2 PLpro Using Molecular Screening and Simulation Approaches
  • Authors: Sayaf, A.M., Ahmad, H., Aslam, M.A., Yeoh, K.K., Wei, D.-Q.
    Journal: Applied Biochemistry and Biotechnology
    Volume: 195
    Issue: 11
    Pages: 6959-6978
    Year: 2023
Article: Exploring the natural products chemical space through a molecular search to discover potential inhibitors that target the hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD)
  • Authors: Sayaf, A.M., Ullah Khalid, S., Hameed, J.A., Wei, D.-Q., Yeoh, K.
    Journal: Frontiers in Pharmacology
    Volume: 14
    Issue: –
    Pages: 1202128
    Year: 2023
Article: Blocking key mutated hotspot residues in the RBD of the omicron variant (B.1.1.529) with medicinal compounds to disrupt the RBD-hACE2 complex using molecular screening and simulation approaches
  • Authors: Khan, A., Randhawa, A.W., Balouch, A.R., Mohammad, A., Wei, D.-Q.
    Journal: RSC Advances
    Volume: 12
    Issue: 12
    Pages: 7318-7327
    Year: 2022
Article: Bioaccumulation of heavy metals in the tissues of Schizothorax plagiostomus at River Swat | Bioacumulação de metais pesados nos tecidos de Plagiostomo esquizotórax em River Swat
  • Authors: Shah, M., Kausar, S., Mian, J.A., Usman, K., Ahmed, D.
    Journal: Brazilian Journal of Biology
    Volume: 82
    Issue: –
    Pages: e243633
    Year: 2022
Article: An Integrated Systems Biology and Network-Based Approaches to Identify Novel Biomarkers in Breast Cancer Cell Lines Using Gene Expression Data
  • Authors: Khan, A., Rehman, Z., Hashmi, H.F., Heng, W., Wei, D.-Q.
    Journal: Interdisciplinary Sciences – Computational Life Sciences
    Volume: 12
    Issue: 2
    Pages: 155-168
    Year: 2020
Article: Immunoinformatics approaches to explore Helicobacter Pylori proteome (Virulence Factors) to design B and T cell multi-epitope subunit vaccine
  • Authors: Khan, M., Khan, S., Ali, A., Khan, A., Wei, D.-Q.
    Journal: Scientific Reports
    Volume: 9
    Issue: 1
    Pages: 13321
    Year: 2019